Naevus and melanoma in renal transplant recipients;Naevus et melanomes chez le greffes d'organe

Nouvelles Dermatologiques

Volumn 17, Issue 9, 1998, Pages 608-609

  Grob, J J ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Melanoma; Naevus

Indexed keywords

CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; HEALTH SURVEY; HUMAN; KIDNEY TRANSPLANTATION; MELANOMA; METASTASIS; NEVUS; RECIPIENT; RISK FACTOR;

EID: 0031701087     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Barker JN., Donald DM. Eruptive dysplastic nevi following renal transplantation. Clin. Exp. Dermatol. 1988 ; 13 : 123-135.
2. Smith CH., McGregor J.-M., Barker JN , Morris RW. et al. M. Excess metanocytic nevi in children with renal allografts. J. Am. Acad. Dermatol. 1993 ; 28 : 51-55.
3. Grob J.-J., Bastujii S., Vaillant L , Roujeau J.-C. et al. Excess of nevi related to immunodeficiency : a study in HIV patients and renal transplant recipients. J. Invest. Dermatol. 1996 ; 107 : 694-697.
4. Hughes BR., Cunliffe WJ., Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. Br. Med. J. 1989 ; 299 : 88-91.
5. De Witt PEJ., De Vann GAM., De Boo TM. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med. Paediatr. Oncol. 1990 ; 18 : 336-338.
6. Greene MH., Young TI., Clark WH J.-R. Malignant melanoma in renal transplant patients. Lancet 1981 ; 1 : 1196
7. Birkeland SA., Kemp E , Hauge M. Renal transplantation and cancer. The scandia transplant material. Tissue Antigens 1975 ; 6 : 28-36.
8. Vilardell J., Oppenheimer F., Talbot-Vright R. Increased risk of malignant tumors in renal transplant recipients receiving cyclosporin. Transplant Proc. 1992 ; 24 : 1948.
9. Stewart T., Tsaï SCJ., Grayson H., Henderson R. et al. Incidence of de novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995 ; 346 : 796-798.
10. Grob J.-J , Gouvernet J., Aymar D., Mostaque A. et al. Count of benign melanocytic nevi as a major indicator of risk for non familial nodular and superficiel spreading and nodular melanoma. Cancer 1990 ; 66 : 387-395.
11. Richard MA., Grob J.-J., Gouvernet J., Culat J. et al. Role of sun exposure on nevus. First study in age-sex-phenotype controlled populations. Arch. Dermatol. 1993 ; 129 : 1280-1285.
12. Curtis RE., Rowling PA., Deeg HJ., Shriner DA Solid cancers after bone marrow transplantation. New. Engl. J. Med. 1997 ; 331 : 345-346.
13. Tindall B , Finlayson Mutimer K., Billson FA., Munro VF. et al. Malignant melanoma associated with human immunodeficiency, virus infection in three homosexual men. J. Am. Acad. Dermatol. 20 : 587 ; 1989.
14. Tucker MA., Misfeldt D., Coleman CNC. Cutaneous melanoma after Hodgkin disease. Ann. Intern. Med. 1985 ; 102 : 37-41.
15. Krutmann J., Elmets CA. Recent studies on mechanisms in photoimmunology. Photochem. Photobiol. 1988 ; 48 : 787-798.
16. Roberts LR., Lynch DH., Samlowski WE., Daynes RA. Ultraviolet radiation and modulation of immune response. In : Norris DA. (ed). Immune mechanisms in cutaneous disease. Marcel Decker, New York 1989 ; pp 167-315.
17. Goettsch W., Garssen J., De Gruidl Fr., Van Loveren H. UV-B and the immune sytem. Thymus 1993 ; 21 : 93-114.
18. Fisher MS., Kripke ML. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982 ; 216 : 1133-1135.